AA
AlphaMark Advisors’s iShares Biotechnology ETF IBB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $7K | Hold |
50
| – | – | ﹤0.01% | 480 |
|
|
2024
Q3 | $7K | Hold |
50
| – | – | ﹤0.01% | 544 |
|
|
2024
Q2 | $7K | Hold |
50
| – | – | ﹤0.01% | 575 |
|
|
2024
Q1 | $7K | Hold |
50
| – | – | ﹤0.01% | 578 |
|
|
2023
Q4 | $7K | Hold |
50
| – | – | ﹤0.01% | 561 |
|
|
2023
Q3 | $6K | Hold |
50
| – | – | ﹤0.01% | 568 |
|
|
2023
Q2 | $6K | Hold |
50
| – | – | ﹤0.01% | 464 |
|
|
2023
Q1 | $6K | Hold |
50
| – | – | ﹤0.01% | 477 |
|
|
2022
Q4 | $7K | Sell |
50
-15
| -23% | -$2.1K | ﹤0.01% | 420 |
|
|
2022
Q3 | $8K | Sell |
65
-20
| -24% | -$2.46K | ﹤0.01% | 446 |
|
|
2022
Q2 | $10K | Sell |
85
-35
| -29% | -$4.12K | ﹤0.01% | 394 |
|
|
2022
Q1 | $16K | Sell |
120
-275
| -70% | -$36.7K | 0.01% | 358 |
|
|
2021
Q4 | $60K | Buy |
395
+10
| +3% | +$1.52K | 0.02% | 219 |
|
|
2021
Q3 | $62K | Hold |
385
| – | – | 0.02% | 218 |
|
|
2021
Q2 | $63K | Buy |
385
+155
| +67% | +$25.4K | 0.02% | 214 |
|
|
2021
Q1 | $35K | Hold |
230
| – | – | 0.01% | 261 |
|
|
2020
Q4 | $35K | Buy |
230
+30
| +15% | +$4.57K | 0.01% | 240 |
|
|
2020
Q3 | $27K | Buy |
+200
| New | +$27K | 0.01% | 253 |
|
|
2015
Q1 | – | Sell |
-190
| Closed | -$58K | – | 307 |
|
|
2014
Q4 | $58K | Sell |
190
-305
| -62% | -$93.1K | 0.04% | 141 |
|
|
2014
Q3 | $135K | Sell |
495
-120
| -20% | -$32.7K | 0.09% | 108 |
|
|
2014
Q2 | $158K | Buy |
615
+130
| +27% | +$33.4K | 0.09% | 107 |
|
|
2014
Q1 | $115K | Buy |
+485
| New | +$115K | 0.07% | 118 |
|
|
2013
Q3 | – | Sell |
-100
| Closed | -$17K | – | 336 |
|
|
2013
Q2 | $17K | Buy |
+100
| New | +$17K | 0.01% | 246 |
|